Event date
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
This is the eighth event in the series, "Creating a successful research program: Combining great mentorship with compelling science and building a diverse and inclusive research environment." This series of presentations with interactive discussions brought to you through a partnership between the National Institute of Neurological Disorders and Stroke (NINDS) and the American Neurological Association (ANA).
  • 2.25 AMA PRA Category 1 Credit™
  • 2.25 Participation
Next-level foundational principles in statistics for the Neurological Researcher.
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Participation
What does the word Placebo mean to you? Randomized, placebo controlled clinical trials have been the mainstay of clinical science for decades. Physicians, and medical researchers may assume that they understand the underlying concepts of a placebo controlled trial, but automatically assuming that rigorous research equates to placebo controlled trials is inaccurate. In this ANA Highlights, we will talk about placebos, what we can learn from them, as well as situations where alternative study designs should be considered. Watch this 20-minute video to learn more.
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Participation
The ANA Highlights Gene Therapy program is chaired by 2024 ANA President, Dr. M. Elizabeth Ross, Nathan Cummings Professor and Head, Laboratory of Neurogenetics and Development, Director, Center for Neurogenetics at Weill Cornell Medicine and Dr. Bryan Traynor, Senior Investigator at the National Institute on Aging (NIA) and the National Center for Advancing Translational Sciences (NCATS), where he leads the RNA Therapeutics Laboratory. This course is brought to you by the ANA Education Innovation Committee, currently chaired by Dr. Michelle C.
  • 5.75 AMA PRA Category 1 Credit™
  • 5.75 Participation
A bite-size learning module series designed to close the knowledge gap about the current state of neurogenetics and the applications of genetic testing.The ANA Highlights Neurogenetics program is chaired by Dr. M. Elizabeth Ross, Nathan Cummings Professor and Head, Laboratory of Neurogenetics and Development, Director, Center for Neurogenetics at Weill Cornell Medicine. The ANA Highlights bite-size learning program is chaired by Michelle C. Johansen, MD, PhD, Assistant Professor of Neurology, Cerebrovascular Division at the Johns Hopkins Hospital.